The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
This study reports on the development and application of theragnostic agents targeting the HER2 receptors in breast tumors. The agent was constructed by loading silica‐coated gold nanorods (GNRs) and a perfluorohexane liquid into PLGA‐PEG nanoparticles, followed by surface conjugation with antibody Herceptin. The particle uptake in human breast cancer MDA‐MB‐231 (HER2‐negative) and BT474 (HER2‐positive)...
Vascular disrupting agents (VDAs) can be used to damage the tumour vasculature, suppressing oxygen and nutrition supply to the tumour tissue. Photoacoustic imaging was used to assess the structural and functional changes of the tumour vasculature and evaluate the efficacy of the VDAs. Tissues are irradiated with short laser pulses and the photoacoustic waves are analyzed to extract vessel size and...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.